Mural Oncology plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MURA research report →
Companywww.muraloncology.com
Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs.
- CEO
- Caroline J. Loew
- IPO
- 2023
- Employees
- 116
- HQ
- Dublin, IE
Price Chart
Valuation
- Market Cap
- $35.38M
- P/E
- -0.30
- P/S
- 0.00
- P/B
- 0.64
- EV/EBITDA
- 0.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -131.47%
- ROIC
- -179.73%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-128,514,000 · 38.05%
- EPS
- $-7.58 · 39.02%
- Op Income
- $-138,262,000
- FCF YoY
- 34.93%
Performance & Tape
- 52W High
- $4.74
- 52W Low
- $0.95
- 50D MA
- $2.08
- 200D MA
- $2.37
- Beta
- 2.96
- Avg Volume
- 170.82K
Get TickerSpark's AI analysis on MURA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 5, 25 | Hickey Benjamin | sell | 15,021 |
| Dec 5, 25 | Hickey Benjamin | sell | 8,637 |
| Dec 5, 25 | Hickey Benjamin | sell | 8,462 |
| Dec 5, 25 | Loew Caroline | sell | 293,059 |
| Dec 5, 25 | Loew Caroline | sell | 379,690 |
| Dec 5, 25 | Loew Caroline | sell | 134,225 |
| Dec 5, 25 | Loew Caroline | sell | 90,025 |
| Dec 5, 25 | Cuss Francis M | sell | 8,637 |
| Dec 5, 25 | Cuss Francis M | sell | 8,462 |
| Dec 5, 25 | Cuss Francis M | sell | 15,021 |
Our MURA Coverage
We haven't published any research on MURA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MURA Report →